Brivaracetam

Common brands: Briviact, Brivaracetam Oral Solution, Vimpat, Keppra Xr, Keppra

Top reporter: Ucb, Inc.

Anti-epileptic Agent [EPC]Benzodiazepine [EPC]Mood Stabilizer [EPC]Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]Corticosteroid [EPC]
8,431
Total Reports
5,707
Serious Reports
427
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.06%)

Patient Demographics

Male
2,988
Female
3,454

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Brivaracetam.

# Reaction Reports % of Total
1 SEIZURE 3,062
23.6%
2 OFF LABEL USE 1,088
8.4%
3 DRUG INEFFECTIVE 924
7.1%
4 FATIGUE 543
4.2%
5 THERAPY INTERRUPTED 480
3.7%
6 SOMNOLENCE 470
3.6%
7 OVERDOSE 452
3.5%
8 DIZZINESS 447
3.4%
9 PRODUCT AVAILABILITY ISSUE 368
2.8%
10 FALL 349
2.7%
11 GENERALISED TONIC-CLONIC SEIZURE 324
2.5%
12 PRODUCT DOSE OMISSION ISSUE 299
2.3%
13 EPILEPSY 292
2.3%
14 PRODUCT USE ISSUE 291
2.2%
15 HEADACHE 290
2.2%
16 AGGRESSION 288
2.2%
17 DEPRESSION 279
2.2%
18 ANXIETY 254
2.0%
19 NAUSEA 249
1.9%
20 MATERNAL EXPOSURE DURING PREGNANCY 234
1.8%
21 INSOMNIA 217
1.7%
22 MEMORY IMPAIRMENT 215
1.7%
23 MULTIPLE-DRUG RESISTANCE 210
1.6%
24 IRRITABILITY 208
1.6%
25 SUICIDAL IDEATION 205
1.6%
26 STATUS EPILEPTICUS 202
1.6%
27 VOMITING 193
1.5%
28 TREMOR 183
1.4%
29 PRODUCT USE IN UNAPPROVED INDICATION 178
1.4%
30 PARTIAL SEIZURES 177
1.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.